CS logo
small CS logo
UPMC Shadyside Radiation Oncology

Pittsburgh, Pennsylvania, United States

About UPMC Shadyside Radiation Oncology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at UPMC Shadyside Radiation Oncology


During the past decade, UPMC Shadyside Radiation Oncology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "UPMC Shadyside Radiation Oncology" #1 sponsor was "David A. Clump, MD, PhD" with 5 trials, followed by "Steven Burton" with 2 trials sponsored, "University of Pittsburgh" with 2 trials sponsored, "Aposense Ltd." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

Clinical Trials Conditions at UPMC Shadyside Radiation Oncology


According to Clinical.Site data, the most researched conditions in "UPMC Shadyside Radiation Oncology" are "Head and Neck Cancer" (3 trials), "4D CT" (1 trials), "Brain Metastases" (1 trials), "Breast Cancer" (1 trials) and "Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "UPMC Shadyside Radiation Oncology" in a lesser frequency.

Clinical Trials Intervention Types at UPMC Shadyside Radiation Oncology


Most popular intervention types in "UPMC Shadyside Radiation Oncology" are "Radiation" (7 trials), "Drug" (3 trials), "Device" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Low Level Laser Therapy" (2 trials), "Stereotactic Radiosurgery" (2 trials), "2-(5-fluoro-pentyl)-2-methyl-malonic-acid ([18F]-ML-10)" (1 trials), "Avelumab" (1 trials) and "Cetuximab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at UPMC Shadyside Radiation Oncology


The vast majority of trials in "UPMC Shadyside Radiation Oncology" are 11 trials for "All" genders.

Clinical Trials Status at UPMC Shadyside Radiation Oncology


Currently, there are NaN active trials in "UPMC Shadyside Radiation Oncology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UPMC Shadyside Radiation Oncology, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in UPMC Shadyside Radiation Oncology, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".